Rethinking antiphospholipid syndrome to guide future management and research
Antiphospholipid syndrome (APS) consists of thrombotic, non-thrombotic and obstetric
clinical manifestations developing in individuals with persistent antiphospholipid antibodies …
clinical manifestations developing in individuals with persistent antiphospholipid antibodies …
Risk factors for damage accrual in primary antiphospholipid syndrome: A retrospective single-center cohort study
A Hoxha, N Perin, M Lovisotto, A Calligaro… - Journal of …, 2024 - Elsevier
Background Despite anticoagulant therapy, a antiphospholipid syndrome (APS) has a
higher rate of recurrent events, which can lead to damage accrual and a negative impact on …
higher rate of recurrent events, which can lead to damage accrual and a negative impact on …
El síndrome antifosfolípido: un nuevo enfoque cuatro décadas después de su inicial definición
MMP de Alejo Rodríguez, LR Jorge… - Medicentro …, 2024 - medicentro.sld.cu
Introducción: El síndrome antifosfolípido es una enfermedad tromboinflamatoria
autoinmune, con manifestaciones macro y microvasculares trombóticas y no trombóticas …
autoinmune, con manifestaciones macro y microvasculares trombóticas y no trombóticas …